Literature DB >> 25749162

Mechanisms of amyloid fibril formation.

N V Dovidchenko1, E I Leonova, O V Galzitskaya.   

Abstract

Amyloid and amyloid-like aggregates are elongated unbranched fibrils consisting of β-structures of separate monomers positioned perpendicular to the fibril axis and stacked strictly above each other. In their physicochemical properties, amyloid fibrils are reminiscent of synthetic polymers rather than usual proteins because they are stable to the action of denaturing agents and proteases. Their mechanical stability can be compared to a spider's web, that in spite of its ability to stretch, is stronger than steel. It is not surprising that a large number of diseases are accompanied with amyloid fibril depositing in different organs. Pathologies provoked by depositing of incorrectly folded proteins include Alzheimer's, Parkinson's, and Huntington's diseases. In addition, this group of diseases involves mucoviscidosis, some types of diabetes, and hereditary cataracts. Each type of amyloidosis is characterized by aggregation of a certain type of protein that is soluble in general, and thus leads to specific distortions of functions of the corresponding organs. Therefore, it is important to understand the process of transformation of "native" proteins to amyloid fibrils to clarify how these molecules acquire such strength and what key elements of this process determine the pathway of erroneous protein folding. This review presents our analysis of complied information on the mechanisms of formation and biochemical properties of amyloid fibrils.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25749162     DOI: 10.1134/S0006297914130057

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  8 in total

Review 1.  Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications.

Authors:  Rita Azevedo; Chloé Jacquemin; Nicolas Villain; François Fenaille; Foudil Lamari; François Becher
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

2.  Identification of fibrillogenic regions in human triosephosphate isomerase.

Authors:  Edson N Carcamo-Noriega; Gloria Saab-Rincon
Journal:  PeerJ       Date:  2016-02-04       Impact factor: 2.984

3.  The Early Phase of β2m Aggregation: An Integrative Computational Study Framed on the D76N Mutant and the ΔN6 Variant.

Authors:  Rui J S Loureiro; Diogo Vila-Viçosa; Miguel Machuqueiro; Eugene I Shakhnovich; Patrícia F N Faísca
Journal:  Biomolecules       Date:  2019-08-14

4.  Antimicrobial and Amyloidogenic Activity of Peptides Synthesized on the Basis of the Ribosomal S1 Protein from Thermus Thermophilus.

Authors:  Stanislav R Kurpe; Sergei Yu Grishin; Alexey K Surin; Olga M Selivanova; Roman S Fadeev; Ulyana F Dzhus; Elena Yu Gorbunova; Leila G Mustaeva; Vyacheslav N Azev; Oxana V Galzitskaya
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

5.  Prediction of Transmembrane Regions, Cholesterol, and Ganglioside Binding Sites in Amyloid-Forming Proteins Indicate Potential for Amyloid Pore Formation.

Authors:  Katja Venko; Marjana Novič; Veronika Stoka; Eva Žerovnik
Journal:  Front Mol Neurosci       Date:  2021-02-10       Impact factor: 5.639

6.  Glycosylated amyloid-like proteins in the structural extracellular polymers of aerobic granular sludge enriched with ammonium-oxidizing bacteria.

Authors:  Yuemei Lin; Clara Reino; Julián Carrera; Julio Pérez; Mark C M van Loosdrecht
Journal:  Microbiologyopen       Date:  2018-03-31       Impact factor: 3.139

Review 7.  The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).

Authors:  Barbara Mroczko; Magdalena Groblewska; Ala Litman-Zawadzka
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

Review 8.  Illuminating amyloid fibrils: Fluorescence-based single-molecule approaches.

Authors:  Lauren J Rice; Heath Ecroyd; Antoine M van Oijen
Journal:  Comput Struct Biotechnol J       Date:  2021-08-13       Impact factor: 7.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.